You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hyperammonemia

Showing 1 - 25 of 80
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hyperammonemia Trial in Changchun (TNP-2092 capsules, TNP-2092 capsules)

Completed
  • Hyperammonemia
  • TNP-2092 placebo capsules
  • TNP-2092 capsules
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Nov 13, 2023

A Non-Interventional Post-Authorization Study of Carbaglu for

Enrolling by invitation
  • Hyperammonemia
  • +2 more
  • carglumic acid
  • Indianapolis, Indiana
    Riley Children's Hospital
Apr 24, 2023

Acute Neonatal Hyperammonaemia

Recruiting
  • Hyperammonemic Encephalopathy
  • user-friendly and widely applicable algorithm to tailor the treatment of acute neonatal hyperammonemia
  • Ghent, Belgium
    Ghent University Hospital - Department of Paediatric Nephrology
Mar 1, 2023

Hyperinsulinism-Hyperammonemia Syndrome Trial in Philadelphia (Vitamin E)

Not yet recruiting
  • Hyperinsulinism-Hyperammonemia Syndrome
  • Vitamin E
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Aug 17, 2022

Carbaglu® for Treatment of MMA and PA in Adults and Pediatrics

Recruiting
  • Hyperammonemia
  • +2 more
  • Carglumic Acid
  • Washington, District of Columbia
  • +1 more
Jun 30, 2022

Hyperammonemia Trial in Belfast (Fezagepras, Sodium phenylbutyrate)

Terminated
  • Hyperammonemia
  • Belfast, Northern Ireland, United Kingdom
    Celerion
Jul 28, 2022

Systemic Biomarkers of Brain Injury From Hyperammonemia

Recruiting
  • Urea Cycle Disorder
  • +5 more
    • Washington, District of Columbia
      Children's National Research Institute
    Oct 25, 2021

    Blood Sugars in Children With Idiopathic Seizures.

    Withdrawn
    • Seizures
    • +2 more
      • Kansas City, Missouri
        Children's Mercy Hospitals and Clinics
      Jan 5, 2021

      Hepatic Encephalopathy Trial (MNK-6105, Placebo, Standard of Care)

      Withdrawn
      • Hepatic Encephalopathy
      • (no location specified)
      Sep 16, 2021

      Inborn Errors of Metabolism Trial in Washington (N-carbamylglutamate)

      Unknown status
      • Inborn Errors of Metabolism
      • Washington, District of Columbia
        Childrens Research Institute
      Feb 13, 2020

      Baby Detect : Genomic Newborn Screening

      Recruiting
      • Congenital Adrenal Hyperplasia
      • +126 more
        • Liege, Wallonia, Belgium
          CRMN, Hôpital La Citadelle
        Jan 24, 2023

        Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX)

        Unknown status
        • Hyperammonemia
        • +3 more
        • Drugs inducing hyperammonemia
        • Paris, France
          AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
        Sep 2, 2019

        Acute Episode of Overt Hepatic Encephalopathy, Hepatic Encephalopathy Trial in Worldwide (ornithine phenylacetate, intravenous

        Completed
        Has Results
        • Acute Episode of Overt Hepatic Encephalopathy
        • Hepatic Encephalopathy
        • ornithine phenylacetate
        • placebo intravenous infusion
        • Phoenix, Arizona
        • +131 more
        Aug 19, 2021

        Epilepsy, Lamotrigine, Sodium Valproate Adverse Reaction Trial (Sodium Valproate 500 Mg Prolonged-Release Oral Tablet,

        Not yet recruiting
        • Epilepsy
        • +2 more
        • Sodium Valproate 500 Mg Prolonged-Release Oral Tablet
        • +2 more
        • (no location specified)
        May 20, 2023

        Characterize Rate of Ureagenesis in Ornithine Transcarbamylase

        Terminated
        • Ornithine Transcarbamylase Deficiency
        • No Intervention
        • Orlando, Florida
          PPD Phase 1 Clinic - Orlando
        Feb 2, 2022

        Acute Liver Failure Trial in New Delhi (Continuous Renal Replacement Therapy (CRRT), Standard Medical Treatment)

        Not yet recruiting
        • Acute Liver Failure
        • Continuous Renal Replacement Therapy (CRRT)
        • Standard Medical Treatment
        • New Delhi, Delhi, India
          Institute of Liver & Biliary Sciences
        Aug 10, 2021

        Pattern of Metabolic Causes of Neonatal Hypoglycemia

        Not yet recruiting
        • Neonatal Hypoglycemia
        • Metabolic Disease
          • (no location specified)
          Jul 24, 2023

          Argininosuccinate Lyase Deficiency, Urea Cycle Disorder, Urea Cycle Disorders, Inborn Trial in Houston (Neo-ASA, Placebo)

          Recruiting
          • Argininosuccinate Lyase Deficiency
          • +3 more
          • Neo-ASA
          • Placebo
          • Houston, Texas
            Baylor College of Medicine
          Aug 5, 2022

          Biomarkers for Inborn Errors of Metabolism

          Completed
          • Inborn Errors of Metabolism
          • Biomarker
            • Tirana, Albania
            • +12 more
            Mar 23, 2022

            Congenital Porto-Systemic Shunt (CPSS) Trial in Worldwide (Shunt Closure)

            Enrolling by invitation
            • Congenital Porto-Systemic Shunt (CPSS)
            • Shunt Closure
            • New Haven, Connecticut
            • +27 more
            Sep 11, 2023

            Hepatic Encephalopathy Trial in Monterrey (L-ornithine-L-aspartate, Lactose)

            Completed
            • Hepatic Encephalopathy
            • Monterrey, Nuevo León, Mexico
              Hospital Universitario "José Eleuterio González"
            May 6, 2021

            Urea Cycle Disorder Trial in Washington (Acetohydroxamic Acid Oral Tablet, No treatment)

            Terminated
            Has Results
            • Urea Cycle Disorder
            • Acetohydroxamic Acid Oral Tablet
            • No treatment
            • Washington, District of Columbia
              Children's National Medical Center
            Nov 18, 2021

            OTC Deficiency Trial in Worldwide (genetic, other, drug)

            Recruiting
            • OTC Deficiency
            • DTX301
            • +4 more
            • Aurora, Colorado
            • +19 more
            Jul 29, 2022

            Chronic Liver Disease Trial in New Delhi (Branched Chain Amino Acid, Whey Protein concentrate powder)

            Completed
            • Chronic Liver Disease
            • Branched Chain Amino Acid
            • Whey Protein concentrate powder
            • New Delhi, Delhi, India
              Institute of Liver and Biliary Sciences
            Jan 28, 2023

            Cirrhosis Trial in United States (SYNB1020, Placebo)

            Terminated
            Has Results
            • Cirrhosis
            • Coronado, California
            • +4 more
            May 11, 2021